DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Allergan, Inc. (NYSE: AGN)

240.25 240.25 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AGN 240.25 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 72132105983.5000
P/E Ratio 0.00
Dividend (Yield) 0.20 (0.0%)
Ex-Dividend Date
Dividend Pay Date
02/25/15
03/20/15
Volume 0
Average Daily Volume 0
Current FY EPS 8.58

Sector

Healthcare

Industry

Drug Makers

Allergan, Inc. (AGN) Description

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc. Website: http://www.allergan.com/

News & Commentary

Can This Pharma Go From Good to Great?

Will Actavis' $66 billion merger with Allergan catapult this company from good to great? Or could a hidden risk derail this global powerhouse?

Teva Eyeing Mylan For $40 Billion

Pharma Spends Big On M&A In Q1 As Teva Pulls Trigger On Mylan

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Valeant Finally Bags Salix for $11 Billion

Ocular Therapeutix Eye-Pain Plug Flops Confirmatory Pivotal Trial

Pershing Square Holdings: First Annual Report

Is It Time for GlaxoSmithKline plc to Change Management?

GlaxoSmithKline's share price has stagnated under CEO Andrew Witty. Is it time for a change?

Merger Arbitrage Mondays - March 23, 2015

See More AGN News...

AGN's Top Competitors

AGN 240.25 (0.00%)
Current stock: AGN
JNJ $101.08 (0.62%)
Current stock: JNJ
RHHBY $36.24 (-0.83%)
Current stock: RHHBY
PFE $35.27 (-0.25%)
Current stock: PFE